Management of Aggressive Histologic Variants of Endometrial Carcinoma at the Tom Baker Cancer Centre between 1984 and 1994

Survival Determinants in Endometrial Cancer Patients: 5-Years Experience

“…Over the past few decades, several studies have demonstrated the prognostic importance of different parameters [6][7][8][9][10][11][12]. In this study, 5-years survival of patients was 89%.…”

“…According to Karateke et al [9] and Bajracharya and Juan [6], nonendometrioid type of endometrial carcinoma tends to have lower survival rates as compared to endometrioid type. In contrast to this, Craighead et al [10], documented that subtypes of EC on endometrial carcinoma prognosis was not remarkable (p>0.05).…”

“…In a large study conducted by Karateke et al [9], fi ve years survival rates in patients with sage 1-IV disease were 83.3%, 80%, 62.5% in stage III and 33.3%, respectively. Craighead et al [10], demonstrate that disease stage was the most important prognostic factor affecting survival. Our fi ndings match well with previous studies, these rates in patients with stage I-II and II-IV disease were 91.7%, and 56.2%, respectively.…”

“…Karateke et al [9], documented that 5-year survival of patients with EC was 76.9%. In a study by Craighead et al [10], a 5-year survival rate of 65% was identifi ed. By contrast, Jhingran et al [18], reported a 5year survival rate of only 42%.…”

“…The overall 5-year survival for all stages is 86%; patients; when diagnosed at a local or regional stage, the 5-year survival rate is 97% and 67% respectively, while distant stage survival decreases to 16% [7]. In order to improve survival of EC patients, clinic-pathological prognostic factors have been studied previously [5][6][7][8][9][10][11][12]. Unfortunately, the importance of predictive factors for the prognosis of patients with EC has not yet been fully established.…”